Radial Immunodiffusion, Albumin
The Radial Immunodiffusion, Albumin test system (product code CJQ) is an in-vitro diagnostic device used in clinical chemistry to measure albumin concentrations in serum using the radial immunodiffusion (Mancini) technique, in which antibody-antigen precipitation rings in a gel matrix are measured to determine protein concentration. It is classified as FDA Class 2, indicating moderate risk, and requires a 510(k) premarket notification. It falls under regulation 21 CFR 862.1035 in the Clinical Chemistry medical specialty. This device is eligible for third-party review under the FDA's accredited persons program.
Research product code CJQ in seconds
The Research Assistant summarizes clearances, adverse event trends and regulation context for a product code — and cites every record.
Free to try · every answer cites its records
Basic Information
- Product Code
- CJQ
- Device Class
- FDA class 2
- Regulation Number
- 862.1035
- Medical Specialty
- Clinical Chemistry
- Review Panel
- CH
- Submission Type
- 1
Device Characteristics
510(k) Clearance History
Related 510(k) Clearances
This FDA classification is associated with 1 510(k) clearance via K numbers.
| K Number | Device Name | Decision Date | Decision | Applicant |
|---|---|---|---|---|
| K811178 | HUMAN IGG-ALBUMIN TEST KIT | May 15, 1981 | Substantially Equivalent | Meloy Laboratories, Inc. |